Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Change in Taxes (2019 - 2025)

Pulmonx (LUNG) has disclosed Change in Taxes for 7 consecutive years, with -$7000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Taxes fell 450.0% to -$7000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $67000.0, a 50.37% decrease, with the full-year FY2024 number at -$38000.0, down 155.88% from a year prior.
  • Change in Taxes was -$7000.0 for Q3 2025 at Pulmonx, down from $68000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $155000.0 in Q4 2023 to a low of -$148000.0 in Q2 2022.
  • A 5-year average of $705.88 and a median of -$2000.0 in 2022 define the central range for Change in Taxes.
  • Peak YoY movement for Change in Taxes: surged 2100.0% in 2023, then plummeted 450.0% in 2025.
  • Pulmonx's Change in Taxes stood at $108000.0 in 2021, then grew by 24.07% to $134000.0 in 2022, then increased by 15.67% to $155000.0 in 2023, then tumbled by 111.61% to -$18000.0 in 2024, then surged by 61.11% to -$7000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Change in Taxes are -$7000.0 (Q3 2025), $68000.0 (Q2 2025), and $24000.0 (Q1 2025).